|
Dr. Demain has been in the forefront of industrial microbiology and biotechnology for over four decades and has been involved in the research and commercialization of a number of fermentation based pharmaceutical processes. He is currently a Fellow at Drew University's Charles A. Dana Institute for Scientists Emeriti. Previously, Dr. Demain was at the Massachusetts Institute of Technology (MIT) for 32 years, where he most recently served as Professor of Industrial Microbiology in the Department of Biology. Before going to MIT, Dr. Demain spent fifteen years at Merck & Co., where he held various positions in R&D and management focused on fermentation microbiology. His leadership in the area of fermentation is evidenced by over 470 publications, 10 books of which he is coeditor or coauthor, 20 U.S. patents and his election to the presidency of the Society for Industrial Microbiology in 1990, membership in the National Academy of Sciences in 1994, the Mexican Academy of Sciences in 1997 and the Hungarian Academy of Sciences in 2001. Dr. Demain received his Ph.D. in Microbiology from University of California. | 